{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T21:06:15Z","timestamp":1788815175311,"version":"build-2803163510"},"reference-count":74,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T00:00:00Z","timestamp":1743984000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["ippan-081"],"award-info":[{"award-number":["ippan-081"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["JPMH20FC1035"],"award-info":[{"award-number":["JPMH20FC1035"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["24390276"],"award-info":[{"award-number":["24390276"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Allergology International"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.alit.2025.03.007","type":"journal-article","created":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T15:33:05Z","timestamp":1744903985000},"page":"372-379","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Recent advances in the diagnosis and treatment of DIHS\/DRESS in 2025"],"prefix":"10.1016","volume":"74","author":[{"given":"Yoshiko","family":"Mizukawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuo","family":"Shiohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.alit.2025.03.007_bib1","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.jaip.2022.02.004","article-title":"Drug-induced hypersensitivity syndrome (DIHS)\/Drug reaction with eosinophilia and systemic symptoms (DRESS): clinical features and pathogenesis","volume":"10","author":"Hama","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.alit.2025.03.007_bib2","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.alit.2019.03.006","article-title":"Drug-induced hypersensitivity syndrome (DiHS)\/drug reaction with eosinophilia and systemic symptoms (DRESS): an update in 2019","volume":"68","author":"Shiohara","year":"2019","journal-title":"Allergol Int"},{"key":"10.1016\/j.alit.2025.03.007_bib3","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1212\/WNL.29.11.1480","article-title":"Phenytoin hypersensitivity: 38 cases","volume":"29","author":"Haruda","year":"1979","journal-title":"Neurology"},{"key":"10.1016\/j.alit.2025.03.007_bib4","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1001\/archinte.1995.00430210033005","article-title":"Anticonvulsant hypersensitivity syndrome","volume":"155","author":"Vittorio","year":"1995","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.alit.2025.03.007_bib5","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1001\/archderm.1981.01650010044023","article-title":"Dapsone hypersensitivity. The sulfone syndrome revisited","volume":"117","author":"Tomecki","year":"1981","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.alit.2025.03.007_bib6","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1001\/archderm.134.9.1108","article-title":"Human herpesvirus 6 infection as a risk factor for the development of severe drug-induced hypersensitivity syndrome","volume":"134","author":"Suzuki","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.alit.2025.03.007_bib7","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1001\/archderm.134.9.1113","article-title":"Severe hypersensitivity syndrome due to sulfasalazine associated with reactivation of human herpesvirus 6","volume":"134","author":"Tohyama","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.alit.2025.03.007_bib8","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1111\/j.1365-2133.2007.07807.x","article-title":"The diagnosis of a DRESS syndrome has been sufficiently established on the basis of typical clinical features and viral reactivations","volume":"156","author":"Shiohara","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.alit.2025.03.007_bib9","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1365-2133.2006.07704.x","article-title":"Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?","volume":"156","author":"Kardaun","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.alit.2025.03.007_bib10","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/all.12602","article-title":"Human herpes virus reactivations and dynamic cytokine profiles in patients with cutaneous adverse drug reactions --a prospective comparative study","volume":"70","author":"Chen","year":"2015","journal-title":"Allergy"},{"key":"10.1016\/j.alit.2025.03.007_bib11","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1111\/bjd.12501","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study","volume":"169","author":"Kardaun","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.alit.2025.03.007_bib12","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.jaad.2024.05.053","article-title":"Risk factors and drugs associated with the development of drug-induced hypersensitivity syndrome\/drug reaction with eosinophilia and systemic symptoms: a population-based cohort study using the Shizuoka Kokuho database","volume":"91","author":"Ubukata","year":"2024","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.alit.2025.03.007_bib13","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/1346-8138.12770","article-title":"Sequelae in 145 patients with drug-induced hypersensitivity syndrome\/drug reaction with eosinophilia and systemic symptoms: survey conducted by the Asian Research Committee on Severe Cutaneous Adverse Reactions (ASCAR)","volume":"42","author":"Kano","year":"2015","journal-title":"J Dermatol"},{"key":"10.1016\/j.alit.2025.03.007_bib14","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.jaad.2023.02.072","article-title":"Drug-induced hypersensitivity syndrome\/drug reaction with eosinophilia and systemic symptoms. Part I. Epidemiology, pathogenesis, clinicopathological features, and prognosis","volume":"90","author":"Wei","year":"2024","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.alit.2025.03.007_bib15","series-title":"Drug hypersensitivity","first-page":"251","article-title":"KanoY. Drug-induced hypersensitivity syndrome and viral reactivation","author":"Shiohara","year":"2007"},{"key":"10.1016\/j.alit.2025.03.007_bib16","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s12016-014-8421-3","article-title":"Crucial role of viral reactivation in the development of severe drug eruptions: a comprehensive review","volume":"49","author":"Shiohara","year":"2015","journal-title":"Clinic Rev Allerg Immunol"},{"key":"10.1016\/j.alit.2025.03.007_bib17","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.jaad.2018.08.052","article-title":"Drug-induced hypersensitivity syndrome\/drug reaction with eosinophilia and systemic symptoms severity score: a useful tool for assessing disease severity and predicting fatal cytomegalovirus disease","volume":"80","author":"Mizukawa","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.alit.2025.03.007_bib18","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1111\/ced.12682","article-title":"Drug reaction with eosinophilia and systemic symptoms\/drug-induced hypersensitivity syndrome: clinical features of 27 patients","volume":"40","author":"Avancini","year":"2015","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.alit.2025.03.007_bib19","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1001\/jamadermatol.2024.1082","article-title":"Drug reaction with eosinophilia and systemic symptoms with pustulosis","volume":"160","author":"Hansen","year":"2024","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.alit.2025.03.007_bib20","doi-asserted-by":"crossref","first-page":"e310","DOI":"10.1111\/jdv.17838","article-title":"Purpura as an indicator of severity in drug-induced hypersensitivity syndrome\/drug reaction with eosinophilia and systemic symptoms: evidence from a 49-case series","volume":"36","author":"Takei","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.alit.2025.03.007_bib21","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/1346-8138.12028","article-title":"Pustular-type drug-induced hypersensitivity syndrome\/drug reaction with eosinophilia and systemic symptoms due to carbamazepine with systemic muscle involvement","volume":"40","author":"Matsuda","year":"2013","journal-title":"J Dermatol"},{"key":"10.1016\/j.alit.2025.03.007_bib22","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.jaad.2022.11.034","article-title":"Demographic and laboratory differences seen between acute generalized exanthematous pustulosis and drug reaction with eosinophilia and systemic symptoms: a cross-sectional analysis","volume":"88","author":"Gallardo","year":"2023","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.alit.2025.03.007_bib23","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1016\/j.jaip.2018.03.001","article-title":"Unusual clinical manifestation of Laryngeal edema in a case of DRESS syndrome","volume":"6","author":"Sim","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.alit.2025.03.007_bib24","first-page":"2377","article-title":"Severe DRESS syndrome after carbamazepine intake in a case with multiple addictions: a case report","volume":"20","author":"Vrinceanu","year":"2020","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.alit.2025.03.007_bib25","first-page":"294","article-title":"Case series on drug reaction with eosinophilia and systemic syndrome (DRESS) with different ocular manifestation","volume":"17","author":"Hui","year":"2021","journal-title":"Mal J Med Health Sci"},{"key":"10.1016\/j.alit.2025.03.007_bib26","first-page":"312","article-title":"Phenytoin-associated hypersensitivity syndrome with features of DRESS and TEN\/SJS","volume":"85","author":"Viera","year":"2010","journal-title":"Cutis"},{"key":"10.1016\/j.alit.2025.03.007_bib27","first-page":"e189","article-title":"Guidelines for the management of drug-induced hypersensitivity syndrome 2023","volume":"52","author":"Mizukawa","year":"2025"},{"key":"10.1016\/j.alit.2025.03.007_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2332\/allergolint.55.1","article-title":"Drug-induced hypersensitivity syndrome (DIHS): a reaction induced by a complex interplay among herpesviruses and antiviral and antidrug immune responses","volume":"55","author":"Shiohara","year":"2006","journal-title":"Allergol Int"},{"key":"10.1016\/j.alit.2025.03.007_bib29","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/DAD.0000000000002742","article-title":"Histopathologic features of drug reaction with eosinophilia and systemic symptoms","volume":"46","author":"Ehsan","year":"2024","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.alit.2025.03.007_bib30","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/cup.13428","article-title":"Facial pustules due to drug-induced hypersensitivity syndrome\/drug reaction with eosinophilia and systemic symptoms may histopathologically mimic eosinophilic pustular folliculitis: a case report","volume":"46","author":"Ogawa","year":"2019","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.alit.2025.03.007_bib31","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s12328-008-0021-4","article-title":"Drug-induced hypersensitivity syndrome associated with reactivation of human herpesvirus 6 presenting with severe hepatic injury","volume":"1","author":"Miura","year":"2008","journal-title":"Clin J Gastroenterol"},{"key":"10.1016\/j.alit.2025.03.007_bib32","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.jaad.2023.05.067","article-title":"Drug reaction eosinophilia and systemic symptoms: clinical phenotypic patterns according to causative drug","volume":"90","author":"Blumenthal","year":"2024","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.alit.2025.03.007_bib33","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/1346-8138.14776","article-title":"Drug-induced hypersensitivity syndrome\/drug reaction with eosinophilia and systemic symptoms due to lamotrigine differs from that due to other drugs","volume":"46","author":"Tashiro","year":"2019","journal-title":"J Dermatol"},{"key":"10.1016\/j.alit.2025.03.007_bib34","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1001\/archderm.140.2.183","article-title":"Association between anticonvulsant hypersensitivity syndrome and human herpesvirus 6 reactivation and hypogammaglobulinemia","volume":"140","author":"Kano","year":"2004","journal-title":"Arch Dermatol"},{"issue":"3 Pt B","key":"10.1016\/j.alit.2025.03.007_bib35","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.jid.2021.11.008","article-title":"Risk of progression to autoimmune disease in severe drug eruption: risk factors and the factor-guided stratification","volume":"142","author":"Mizukawa","year":"2022","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.alit.2025.03.007_bib36","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jdermsci.2012.10.002","volume":"69","author":"Ogawa","year":"2013","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.alit.2025.03.007_bib37","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/bjd.12948","article-title":"Elevated serum thymus and activation-regulated chemokine (TARC\/CCL17) relates to reactivation of human herpesvirus 6 in drug reaction with eosinophilia and systemic symptoms (DRESS)\/drug-induced hypersensitivity syndrome (DIHS)","volume":"171","author":"Ogawa","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.alit.2025.03.007_bib38","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1111\/bjd.16132","article-title":"Serum thymus and activation-regulated chemokine is associated with the severity of drug reaction with eosinophilia and systemic symptoms\/drug-induced hypersensitivity syndrome","volume":"178","author":"Nakamura-Nishimura","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.alit.2025.03.007_bib39","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1111\/j.1398-9995.2007.01553.x","article-title":"Utility of the lymphocyte transformation test in the diagnosis of drug sensitivity: dependence on its timing and the type of drug eruption","volume":"62","author":"Kano","year":"2007","journal-title":"Allergy"},{"key":"10.1016\/j.alit.2025.03.007_bib40","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.1016\/j.jaip.2023.06.065","article-title":"Drug-induced hypersensitivity syndrome\/drug reaction with eosinophilia and systemic symptoms: predictive score and outcomes","volume":"11","author":"Mizukawa","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.alit.2025.03.007_bib41","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1001\/jamadermatol.2023.4450","article-title":"Management of adult patients with drug reaction with eosinophilia and systemic symptoms: a Delphi-based international consensus","volume":"160","author":"Br\u00fcggen","year":"2024","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.alit.2025.03.007_bib42","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1365-2133.2006.07238.x","article-title":"Several herpesviruses can reactivate in a severe drug-induced multiorgan reaction in the same sequential order as in graft-versus-host disease","volume":"155","author":"Kano","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.alit.2025.03.007_bib43","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/all.12410","article-title":"The dynamics of herpesvirus reactivations during and after severe drug eruptions: their relation to the clinical phenotype and therapeutic outcome","volume":"69","author":"Ishida","year":"2014","journal-title":"Allergy"},{"key":"10.1016\/j.alit.2025.03.007_bib44","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-69054-7","article-title":"Viral reactivation and clinical outcomes in drug reaction with eosinophilia and systemic symptoms (DRESS)","volume":"14","author":"Chan","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.alit.2025.03.007_bib45","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1001\/jamadermatol.2013.2018","article-title":"French Study Group of Cutaneous Drug Adverse Reactions. Saliva polymerase chain reaction assay for detection and follow-up of herpesvirus reactivation in patients with drug reaction with eosinophilia and systemic symptoms (DRESS)","volume":"149","author":"Descamps","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.alit.2025.03.007_bib46","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1111\/jdv.19425","article-title":"Retrospective study on the association of human herpesvirus reactivation with severe DRESS: a description of blood and skin reactivations","volume":"37","author":"Marcombes","year":"2023","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.alit.2025.03.007_bib47","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/s41584-024-01167-9","article-title":"Epstein-Barr virus as a potentiator of autoimmune diseases","volume":"20","author":"Robinson","year":"2024","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.alit.2025.03.007_bib48","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.623944","article-title":"Epstein Barr virus and autoimmune responses in systemic lupus erythematosus","volume":"11","author":"Jog","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.alit.2025.03.007_bib49","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1001\/archdermatol.2009.195","article-title":"Cytomegalovirus disease during severe drug eruptions: report of 2 cases and retrospective study of 18 patients with drug-induced hypersensitivity syndrome","volume":"145","author":"Asano","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.alit.2025.03.007_bib50","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.jaad.2012.10.017","article-title":"Short- and long-term outcomes of 34 patients with drug-induced hypersensitivity syndrome in a single institution","volume":"68","author":"Ushigome","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.alit.2025.03.007_bib51","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/cid\/ciw668","article-title":"Definitions of cytomegalovirus infection and disease in transplant patients for use in clinical trials","volume":"64","author":"Ljungman","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.alit.2025.03.007_bib52","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1684\/ejd.2017.3117","article-title":"Herpes simplex virus reactivation: is it common or rare in drug-induced hypersensitivity syndrome\/drug reaction with eosinophilia and systemic symptoms?","volume":"27","author":"Kurata","year":"2017","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.alit.2025.03.007_bib53","doi-asserted-by":"crossref","first-page":"206","DOI":"10.2340\/00015555-1317","article-title":"Herpes zoster in patients with drug-induced hypersensitivity syndrome\/DRESS","volume":"92","author":"Kano","year":"2012","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.alit.2025.03.007_bib54","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s13337-022-00769-9","article-title":"Refractory atypical trigeminal neuralgia associated with reactivated herpesvirus infection: pathogenetic link and efficacy of combination antiviral therapy","volume":"33","author":"Maltsev","year":"2022","journal-title":"Virusdisease"},{"key":"10.1016\/j.alit.2025.03.007_bib55","first-page":"339","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome and myocarditis: a case report and literature review on fatal complications of reactivated viral infections","volume":"23","author":"Tajerian","year":"2024","journal-title":"Iran J Allergy Asthma Immunol"},{"key":"10.1016\/j.alit.2025.03.007_bib56","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1684\/ejd.2011.1280","article-title":"Relationship between cytomegalovirus reactivation and dermatomyositis","volume":"21","author":"Kanetaka","year":"2011","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.alit.2025.03.007_bib57","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1111\/1346-8138.15409","article-title":"Demographic and clinical characteristics of cytomegalovirus reactivation in dermatomyositis","volume":"47","author":"Sekiguchi","year":"2020","journal-title":"J Dermatol"},{"key":"10.1016\/j.alit.2025.03.007_bib58","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/ijd.13799","article-title":"Bullous pemphigoid complicated by cytomegalovirus disease as a manifestation of immune reconstitution inflammatory syndrome: retrospective analyses of our institutional cases and literature review","volume":"57","author":"Narita","year":"2018","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.alit.2025.03.007_bib59","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1093\/ced\/llae372","article-title":"CMV complications in DIHS\/DRESS: importance of routine monitoring and early therapeutic intervention","volume":"50","author":"Takei","year":"2025","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.alit.2025.03.007_bib60","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/1346-8138.15294","article-title":"Influence of corticosteroid therapy on viral reactivation in drug-induced hypersensitivity syndrome\/drug reaction with eosinophilia and systemic symptoms","volume":"47","author":"Tohyama","year":"2020","journal-title":"J Dermatol"},{"key":"10.1016\/j.alit.2025.03.007_bib61","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/j.1468-3083.2012.04547.x","article-title":"Clinical course of drug-induced hypersensitivity syndrome treated without systemic corticosteroids","volume":"27","author":"Uhara","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.alit.2025.03.007_bib62","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.annder.2021.02.002","article-title":"Impact of systemic to topical steroids switch on the outcome of drug reaction with eosinophilia and systemic symptoms (DRESS): a monocenter retrospective study of 20 cases","volume":"148","author":"Brin","year":"2021","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.alit.2025.03.007_bib63","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s40257-023-00776-6","article-title":"Systemic versus topical corticosteroids in the treatment of DRESS: a retrospective cohort study followed by a meta-analysis","volume":"24","author":"Lian","year":"2023","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.alit.2025.03.007_bib64","doi-asserted-by":"crossref","first-page":"333","DOI":"10.2332\/allergolint.10-RAI-0260","article-title":"Recognition of immune reconstitution syndrome necessary for better management of patients with severe drug eruptions and those under immunosuppressive therapy","volume":"59","author":"Shiohara","year":"2010","journal-title":"Allergol Int"},{"key":"10.1016\/j.alit.2025.03.007_bib65","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/1346-8138.16230","article-title":"Is steroid pulse therapy a suitable treatment for drug-induced hypersensitivity syndrome\/drug reaction with eosinophilia and systemic symptoms? A systematic review of case reports in patients treated with corticosteroids in Japan","volume":"49","author":"Hashizume","year":"2022","journal-title":"J Dermatol"},{"key":"10.1016\/j.alit.2025.03.007_bib66","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.jaad.2023.02.073","article-title":"Drug-induced hypersensitivity syndrome\/drug reaction with eosinophilia and systemic symptoms. Part II diagnosis and management","volume":"90","author":"Wei","year":"2024","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.alit.2025.03.007_bib67","doi-asserted-by":"crossref","DOI":"10.1111\/dth.15785","article-title":"How to recognize and manage challenging DRESS cases: two case reports and a review of the literature","volume":"35","author":"Ak","year":"2022","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.alit.2025.03.007_bib68","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1001\/jamadermatol.2020.0048","article-title":"Evaluation of cyclosporine for the treatment of DRESS syndrome","volume":"156","author":"Nguyen","year":"2020","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.alit.2025.03.007_bib69","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.jdcr.2019.07.004","article-title":"Drug-induced hypersensitivity syndrome with myocardial involvement treated with tofacitinib","volume":"5","author":"Damsky","year":"2019","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.alit.2025.03.007_bib70","doi-asserted-by":"crossref","first-page":"e221","DOI":"10.1111\/1346-8138.16341","article-title":"Sequential screening of biomarkers in a case of drug-induced hypersensitivity syndrome\/drug reaction with eosinophilia and systemic symptoms occurring with virus reactivation and autoimmune disease","volume":"49","author":"Lee","year":"2022","journal-title":"J Dermatol"},{"key":"10.1016\/j.alit.2025.03.007_bib71","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/s41598-020-79397-6","article-title":"Continuous monitoring of neutrophils to lymphocytes ratio for estimating the onset, severity, and subsequent prognosis of immune related adverse events","volume":"11","author":"Matsukane","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.alit.2025.03.007_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117788","article-title":"The role of biomarkers in diagnosis of COVID-19 - a systematic review","volume":"254","author":"Kermali","year":"2020","journal-title":"Life Sci"},{"key":"10.1016\/j.alit.2025.03.007_bib73","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2018-225528","article-title":"Aggressive treatment in paediatric or young patients with drug-induced hypersensitivity syndrome (DIHS)\/drug reaction with eosinophilia and systemic symptoms (DRESS) is associated with future development of type III polyglandular autoimmune syndrome","volume":"2018","author":"Morita","year":"2018","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.alit.2025.03.007_bib74","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1111\/j.1365-2133.2007.07784.x","article-title":"Sclerodermoid graft-versus-host disease-like lesions occurring after drug-induced hypersensitivity syndrome","volume":"156","author":"Kano","year":"2007","journal-title":"Br J Dermatol"}],"container-title":["Allergology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1323893025000462?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1323893025000462?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T18:49:29Z","timestamp":1762368569000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1323893025000462"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":74,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S1323893025000462"],"URL":"https:\/\/doi.org\/10.1016\/j.alit.2025.03.007","relation":{},"ISSN":["1323-8930"],"issn-type":[{"value":"1323-8930","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent advances in the diagnosis and treatment of DIHS\/DRESS in 2025","name":"articletitle","label":"Article Title"},{"value":"Allergology International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.alit.2025.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Japanese Society of Allergology. Published by Elsevier B.V\u00e9","name":"copyright","label":"Copyright"}]}}